Skip to main content
OpenTrials

Clinical trial condition

Differentiated Thyroid Cancer

Explore clinical trials studying Differentiated Thyroid Cancer. Study availability and eligibility vary by location and protocol.

37 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Differentiated Thyroid Cancer trial results

Completed

Diagnosing Thyroid Cancer Using a Blood Test

NCT01586520

Conditions
Differentiated Thyroid Cancer, Endocrine Gland Neoplasms, Endocrine System Diseases, +5 more
Locations
  • Sir Bobby Robson Cancer Researhc Unit Newcastle upon Tyne, Tyne and Wear, United Kingdom
  • Sir Bobby Robson Cancer Research Unit, Northern Centre for cancer care Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

NCT00295763

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +12 more
Locations
  • University of Colorado Health Sciences Centre Aurora, Colorado, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Ohio State University Columbus, Ohio, United States
  • MD Anderson Cancer Centre Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Exelixis Clinical Site #2 Newport Beach, California, United States
  • Exelixis Clinical Site #98 Sacramento, California, United States
  • Exelixis Clinical Site #69 San Francisco, California, United States
  • Exelixis Clinical Site #10 Stanford, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Exelixis Clinical Site #53 Gilbert, Arizona, United States
  • Exelixis Clinical Site #18 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Duarte, California, United States
  • Exelixis Clinical Site #20 La Jolla, California, United States
View all 124 locations
View Trial Details

Related conditions